The Leadership Team at Providence Therapeutics is responsible for steering the company's strategic vision and operational direction, focusing on the development and commercialization of personalized mRNA cancer vaccines. This diverse team of experts collaborates on scientific, regulatory, and business initiatives to drive innovation and ensure the successful advancement of therapies for ovarian cancer, while also overseeing compliance, intellectual property, and stakeholder engagement.
Aleksandra Pastrak M...
Chief Medical Officer
Bradley Sorenson
President & CEO
Charlotte Dubé, Ph.D...
Principal Scientist,preclinica...
Daran Simpson, Prosc...
Vice President Shared Services
Eric Marcusson
Co-Founder, Board Member & Cha...
Jennifer Bryan
Vice President of Intellectual...
Mark Gilmour
Vice President Regulatory Affa...
Natalia Martin Orozc...
Chief Science Officer
View all